Renub Research, profile picture
Uploaded byRenub Research
786 views

Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis

The pediatric vaccines market has experienced significant growth, expected to exceed $23 billion by 2015, driven by major vaccines like Prevnar and Rotarix. Although certain vaccine segments like combinations and boosters are expected to stagnate, proprietary vaccines will continue to dominate the market share. The report also provides comprehensive insights into immunization coverage, case numbers, and market challenges from 2001 to 2015 across various regions.

Downloaded 27 times
Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Renub Research www.renub.com Published: December, 2012 Copyright © 2012 Renub Research – All Rights Reserved
© Renub Research Page 2 of 18 Pediatric Vaccines Market Analysis Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution. It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011. In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country. DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations. Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary
© Renub Research Page 3 of 18 Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market. Pediatric Vaccines Covered in this Report are as follows: Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines, Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other Pediatric Vaccines All the Pediatric Vaccines in this Report have been Studied from Four View Points:  Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011  Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015  Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015  Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015 Key Topics Covered in the Report  Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)  Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)  Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)  By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)  By Region - Pediatric Disease Cases (2001 – 2011)  Pediatric Vaccines Doses and Forecast (2005 – 2015)  Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)  All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)  Growth Drivers of Pediatric Vaccines Market  Challenges of Pediatric Vaccines Market
© Renub Research Page 4 of 18 Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non- printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
© Renub Research Page 5 of 18 About Us RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets. For more information on us or to view any of our sample work you can mail us at info@renub.com
© Renub Research Page 6 of 18 Published By RReennuubb RReesseeaarrcchh A–116B, Sector–27 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com © Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Renub Research, 2012 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers
© Renub Research Page 7 of 18 Table of Contents 1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015) 3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015) 4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015) 5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015) 5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market 5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market 5.3 Worldwide – Pediatric Proprietary Vaccines Market 6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast 6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015) 6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011) 6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses 6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines 6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines 6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015) 6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011) 6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses 6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines 6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines 6.3 Polio Vaccines and Forecast (2005 – 2015) 6.3.1 Number of Polio Cases (2001 – 2011) 6.3.2 Number of Polio Vaccines Doses 6.3.3 Immunization Coverage of Polio Vaccines 6.3.4 Market Size of Polio Vaccines 6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015) 6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011) 6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses 6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines 6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines 6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)
© Renub Research Page 8 of 18 6.5.1 Number of Pneumococcal Cases (2000) 6.5.2 Number of Pneumococcal Vaccines Doses 6.5.3 Immunization Coverage of Pneumococcal Vaccines 6.5.4 Market Size of Pneumococcal Vaccines 6.6 Rotavirus Vaccine and Forecast (2006 – 2015) 6.6.1 Number of Rotavirus Cases (2008 & 2009) 6.6.2 Number of Rotavirus Vaccines Doses 6.6.3 Immunization Coverage of Rotavirus Vaccines 6.6.4 Market Size of Rotavirus Vaccine 6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015) 6.7.1 Number of Hepatitis Pediatric Vaccines Doses 6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines 6.7.3 Market Size of Hepatitis Pediatric Vaccines 6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015) 6.8.1 Number of Varicella/Chicken Pox Vaccines Doses 6.8.2 Market Size of Varicella/Chicken Pox Vaccines 6.9 Other Pediatric Vaccines and Forecast (2005 – 2015) 6.9.1 Market Size of Other Pediatric Vaccines 7. Growth Drivers of Pediatric Vaccines Market 7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done Error! Bookmark not defined. 7.1.1 Rotavirus Vaccine Introduction 7.1.2 Financial Challenges 7.1.3 Cost Effective 7.1.4 Future Steps 7.1.5 Conclusion 7.2 GAVI Model Increases Vaccine Manufacturers 7.2.1 The Partnership Model 7.2.2 The Business Model 7.3 WHO Global Vaccine Action Plan (2011 - 2020) 8. Challenges of Pediatric Vaccine Market 8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines 8.2 Impediment in Pediatric Vaccine Research & Development
© Renub Research Page 9 of 18 8.3 Barriers to New Entrants in the Pediatric Vaccines Market
© Renub Research Page 10 of 18 List of Figures Figure 2-1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011 Figure 2-2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 3-1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011 Figure 3-2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015 Figure 5-1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011 Figure 5-2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 – 2015 Figure 5-3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011 Figure 5-4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 – 2015 Figure 5-5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011 Figure 5-6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015 Figure 6-1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011 Figure 6-2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015 Figure 6-3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011 Figure 6-4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 – 2015 Figure 6-5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011 Figure 6-6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 – 2015 Figure 6-7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 – 2010 Figure 6-8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011 Figure 6-9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015 Figure 6-10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011 Figure 6-11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015 Figure 6-12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 – 2011 Figure 6-13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 – 2015
© Renub Research Page 11 of 18 Figure 6-14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011 Figure 6-15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015 Figure 6-16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011 Figure 6-17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 – 2015 Figure 6-18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011 Figure 6-19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015 Figure 6-20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011 Figure 6-21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015 Figure 6-22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011 Figure 6-23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 – 2015 Figure 6-24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 – 2011 Figure 6-25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 – 2015 Figure 6-26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025 Figure 6-27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011 Figure 6-28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 – 2015 Figure 6-29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 – 2011 Figure 6-30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 – 2015 Figure 6-31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011 Figure 6-32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015 Figure 6-33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011 Figure 6-34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 – 2015 Figure 6-35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011 Figure 6-36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 – 2015 Figure 6-37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011 Figure 6-38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015 Figure 6-39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011 Figure 6-40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015
© Renub Research Page 12 of 18 Figure 6-41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011 Figure 6-42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015 Figure 6-43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010 Figure 6-44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011 Figure 6-45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 6-46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011 Figure 6-47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 – 2015 Figure 6-48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011 Figure 6-49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015 Figure 6-50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011 Figure 6-51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 7-1: Prices of Childhood Vaccines (US$), 2011 Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012 Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets
© Renub Research Page 13 of 18 List of Tables Table 4-1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011 Table 4-2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015 Table 6-1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011 Table 6-2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011 Table 6-3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011 Table 6-4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 – 2011 Table 6-5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011 Table 6-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011 Table 6-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011 Table 6-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011 Table 6-9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011 Table 6-10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000 Table 6-11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number), 2008 – 2009 Table 6-12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009 Table 7-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020 Table 7-2: Goal-Level Indicators, 2015 & 2020
© Renub Research Page 14 of 18 Related Reports Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015) Asia Medical Tourism Analysis and Forecast to 2015 Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast Genetic Testing Market and Forecast - Global Analysis 2010 – 2015 USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015) Global Osteoporosis Market & Drugs Analysis 2010 – 2015 Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast
© Renub Research Page 15 of 18 Our Partial List of Clients Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Rep e Inv Medicas SA de Innogenetics
© Renub Research Page 16 of 18 Order Form Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to info@renub.com Format Report Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Single User (Email from Publisher) Hard Copy (Mail Delivery) CD – Rom (Mail Delivery) Global Site License (Multiple User License) US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200 For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and- forecast-worldwide-analysis-86 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=86&pid=1325 To pay by Wire Transfer, please, fill in your contact details in the form below:
© Renub Research Page 17 of 18 Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:
© Renub Research Page 18 of 18 3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA) Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

More Related Content

PPTX
Megafund for Rare Diseases
byEURORDIS Rare Diseases Europe
 
PDF
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines -...
byRenub Research
 
PDF
Global vaccine market forecast to 2017
byShushmul Maheshwari
 
DOCX
Monoclonal antibodies (m abs) market
byManjushaGirme
 
PPTX
Global vaccine market Keyword Market PPT 2021-26 | Enhancing Huge Growth and ...
byIMARC Group
 
PPTX
COVID19| What's next
bypaul young cpa, cga
 
PPTX
Race for COVID19 Vaccine and Treatments
bypaul young cpa, cga
 
PPTX
PPT- Unmanned Ground Vehicle Market by Product Type, Distribution Channel, En...
byIMARC Group
 
Megafund for Rare Diseases
byEURORDIS Rare Diseases Europe
 
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines -...
byRenub Research
 
Global vaccine market forecast to 2017
byShushmul Maheshwari
 
Monoclonal antibodies (m abs) market
byManjushaGirme
 
Global vaccine market Keyword Market PPT 2021-26 | Enhancing Huge Growth and ...
byIMARC Group
 
COVID19| What's next
bypaul young cpa, cga
 
Race for COVID19 Vaccine and Treatments
bypaul young cpa, cga
 
PPT- Unmanned Ground Vehicle Market by Product Type, Distribution Channel, En...
byIMARC Group
 

What's hot

PPT
09 CeoMeeting- Session 4- Medicines for Malaria
byMLSCF
 
PDF
Molecular diagnostics market & forecast (by application, technology, countrie...
byRenub Research
 
PDF
IVD Market Size and Growth Trend
byBruce Carlson
 
PDF
Global vaccine market features n trends
byNational Institute of Biologics
 
PDF
Zoonotic Disease Treatment Market 10-Year Market Forecast and Trends Analysis...
byMonica Nerkar
 
PPTX
M&A in pharmaceutical industry between india and italy
byVishal Singh
 
PDF
A Small Biotech/Pharma Company with Great Potentials...Novavax's Conference P...
byDrMuni Neurophysiologist
 
PPTX
Infant Radiant Warmer Market is expected to reach US$ 2,420.44 million by 2027
byNikhilkumar1082
 
PDF
Diagnostics and personalized medicine
byWinton Gibbons
 
PPTX
Vaccine industry overview
byNaveen Kumar
 
PDF
Download Global breast cancer vaccine market & clinical pipeline outlook ...
byKuicK Research
 
PDF
Kim_Dongok_VRX_ENDP
byDongok Kim
 
PDF
United States IVD Market (By Application Segments, Products, Region, End User...
byiGATE RESEARCH
 
PDF
Biological Safety Testing Market Size, Product Analysis and Applications, 201...
bySignitech
 
PDF
Medicines outlook through_2016_report (1)
byJuan Manuel Santa Maria
 
PPTX
Race for COVID19 Vaccine
bypaul young cpa, cga
 
09 CeoMeeting- Session 4- Medicines for Malaria
byMLSCF
 
Molecular diagnostics market & forecast (by application, technology, countrie...
byRenub Research
 
IVD Market Size and Growth Trend
byBruce Carlson
 
Global vaccine market features n trends
byNational Institute of Biologics
 
Zoonotic Disease Treatment Market 10-Year Market Forecast and Trends Analysis...
byMonica Nerkar
 
M&A in pharmaceutical industry between india and italy
byVishal Singh
 
A Small Biotech/Pharma Company with Great Potentials...Novavax's Conference P...
byDrMuni Neurophysiologist
 
Infant Radiant Warmer Market is expected to reach US$ 2,420.44 million by 2027
byNikhilkumar1082
 
Diagnostics and personalized medicine
byWinton Gibbons
 
Vaccine industry overview
byNaveen Kumar
 
Download Global breast cancer vaccine market & clinical pipeline outlook ...
byKuicK Research
 
Kim_Dongok_VRX_ENDP
byDongok Kim
 
United States IVD Market (By Application Segments, Products, Region, End User...
byiGATE RESEARCH
 
Biological Safety Testing Market Size, Product Analysis and Applications, 201...
bySignitech
 
Medicines outlook through_2016_report (1)
byJuan Manuel Santa Maria
 
Race for COVID19 Vaccine
bypaul young cpa, cga
 

Similar to Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis

PDF
Global Vaccine Market
byRenub Research
 
PDF
Rotavirus Prophylaxis Market Size, Growth, Trend & Forecast Report (2024-2032...
bysheetalkarande2
 
PPTX
Vaccine Adjuvants Market by Product Type, Distribution Channel, End User 2024...
byIMARC Group
 
PDF
Measles, Mumps, Rubella Vaccine Market Outlook 2030: Key Drivers, Challenges ...
byKumar Satyam
 
PPTX
Adult Vaccines Market Drivers, Trends, and Forecasts by 2031
byJohnAnderson368440
 
PPTX
Adult Vaccines Market Drivers, Trends, and Forecasts by 2031
byJohnAnderson368440
 
PDF
India Influenza Vaccine Market Segmentation Insights, From USD 26.76 Million ...
byKumar Satyam
 
PPTX
Navigating-the-Adult-Vaccines-Market.pptx
byJohnAnderson368440
 
PPTX
Navigating-the-Adult-Vaccines-Market.pptx
byJohnAnderson368440
 
PPTX
Navigating-the-Adult-Vaccines-Market.pptx
byJohnAnderson368440
 
PDF
The Evolving Vaccines Market: Growth, Innovation, and Future Trends
byPramilapawar4
 
DOCX
Vaccination Updates What Parents Need to Know in 2025.docx
bydrlizaedwards95
 
DOCX
Global Vaccines Market
byEmilineAppelhans
 
PDF
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult...
byReportsnReports
 
PPT
BuccalVax Presntation - Intro to Marketing
byPeter F. Muratore II
 
PPTX
Pediatric Vaccines Market Growth, Demand and Challenges of the Key Industry P...
byIMARC Group
 
PDF
China Vaccine Market, Size, Forecast 2023-2027
byRenub Research
 
PDF
Un who global vaccine market features and trends
byPublicLeaks
 
PPTX
Pediatric Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis –...
byStratview Research
 
PDF
World vaccines makret 2013 2023
byVisiongain
 
Global Vaccine Market
byRenub Research
 
Rotavirus Prophylaxis Market Size, Growth, Trend & Forecast Report (2024-2032...
bysheetalkarande2
 
Vaccine Adjuvants Market by Product Type, Distribution Channel, End User 2024...
byIMARC Group
 
Measles, Mumps, Rubella Vaccine Market Outlook 2030: Key Drivers, Challenges ...
byKumar Satyam
 
Adult Vaccines Market Drivers, Trends, and Forecasts by 2031
byJohnAnderson368440
 
Adult Vaccines Market Drivers, Trends, and Forecasts by 2031
byJohnAnderson368440
 
India Influenza Vaccine Market Segmentation Insights, From USD 26.76 Million ...
byKumar Satyam
 
Navigating-the-Adult-Vaccines-Market.pptx
byJohnAnderson368440
 
Navigating-the-Adult-Vaccines-Market.pptx
byJohnAnderson368440
 
Navigating-the-Adult-Vaccines-Market.pptx
byJohnAnderson368440
 
The Evolving Vaccines Market: Growth, Innovation, and Future Trends
byPramilapawar4
 
Vaccination Updates What Parents Need to Know in 2025.docx
bydrlizaedwards95
 
Global Vaccines Market
byEmilineAppelhans
 
Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult...
byReportsnReports
 
BuccalVax Presntation - Intro to Marketing
byPeter F. Muratore II
 
Pediatric Vaccines Market Growth, Demand and Challenges of the Key Industry P...
byIMARC Group
 
China Vaccine Market, Size, Forecast 2023-2027
byRenub Research
 
Un who global vaccine market features and trends
byPublicLeaks
 
Pediatric Vaccines Market Size, Share, Trend, Forecast, & Industry Analysis –...
byStratview Research
 
World vaccines makret 2013 2023
byVisiongain
 

More from Renub Research

PDF
Point of care testing market and forecast to 2016 global analysis
byRenub Research
 
PDF
Singapore Medical Tourism Analysis and Forecast
byRenub Research
 
PDF
India probiotic dairy products (yogurt, drink, ice cream) market, volume & fo...
byRenub Research
 
PDF
India cold storage market
byRenub Research
 
PDF
India frozen food market
byRenub Research
 
PDF
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...
byRenub Research
 
PDF
Cardivascular bioimplant market analysis publisher
byRenub Research
 
PDF
South korea medical tourism number of medical tourists & medical tourism mark...
byRenub Research
 
PDF
Worldwide smbg market
byRenub Research
 
PDF
India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vege...
byRenub Research
 
PDF
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015
byRenub Research
 
PDF
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015
byRenub Research
 
PDF
4 g (lte and wimax) service revenuemarket analysis and its opportunities for ...
byRenub Research
 
Point of care testing market and forecast to 2016 global analysis
byRenub Research
 
Singapore Medical Tourism Analysis and Forecast
byRenub Research
 
India probiotic dairy products (yogurt, drink, ice cream) market, volume & fo...
byRenub Research
 
India cold storage market
byRenub Research
 
India frozen food market
byRenub Research
 
Personalized Medicine Diagnostics (Flow Cytometry, Sepsis Immunos, Routine Co...
byRenub Research
 
Cardivascular bioimplant market analysis publisher
byRenub Research
 
South korea medical tourism number of medical tourists & medical tourism mark...
byRenub Research
 
Worldwide smbg market
byRenub Research
 
India Frozen Food (Poultry, Fish/Seafood, Red Meat, Dessert, Snacks and Vege...
byRenub Research
 
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015
byRenub Research
 
India e retail (e-tailing) market, companies revenue analysis & forecast to 2015
byRenub Research
 
4 g (lte and wimax) service revenuemarket analysis and its opportunities for ...
byRenub Research
 

Recently uploaded

PPTX
2025 Diabetes Management: Technology, Pharmacotherapy & Individualized Care
byArchitMehta11
 
PPTX
2025 May 29th Rabies TOT MP NCDC Dr Khan Amir Maroof.pptx
byKhan Amir Maroof
 
PDF
FUTURE OF FITNESS 2025 - FITLIFE CLUB NETWORK KEYNOTE - SEATTLE 2025 BRYAN OR...
byBryan K. O'Rourke
 
PPTX
GLP-1 Medicines From Metabolic Agents to Multi System Therapeutics
byArchitMehta11
 
PDF
Hyaluronic Acid Role in Combination Therapy: Advances & Application
byReza Aminnejad
 
PDF
Osteoarthritis.pdf
byGhaidaa Al-Sarayreh
 
PDF
HPM Freedom ( Metsulfuron Methyl 20% WP )
byHpm India
 
PPTX
THE BIOMECHANICS OF THE JOINT MOTIONS.pptx
bydrnidhimnd
 
PPTX
Flame Photometer – Standard Operating Procedure (SOP).pptx
byDebendra Suman
 
PDF
physiology pf Prgnancy, Hormones and implications
byMedicoseAcademics
 
PDF
Conc Urine formation and related disorders
byMedicoseAcademics
 
PDF
Olaparib Tablet For breast and ovarian cancers
byLetsMeds
 
PDF
Role Of Lenalidomide in Multiple Myeloma Treatment
byLetsMeds
 
PDF
Physiology of Monthly Female Menstrual Cycle
byMedicoseAcademics
 
PDF
Venetoclax Tablets for Leukemia Treatment
byLetsMeds
 
PDF
Zoledronic Acid Injection Info and price
byLetsMeds
 
PPTX
PHOBIA IN DETAILS FOR MEDICAL AND NURSING STUDENTS.pptx
byDr.Prakashkumar More
 
PPTX
OBSESSIVE COMPULSIVE DISORDER(OCD) IN DETAIL.pptx
byDr.Prakashkumar More
 
PPTX
SONIA Trial Glucocorticoids for Community Acquired Pneumonia in Kenya
byArchitMehta11
 
PPTX
SEX COUNSELLING FOR EVERYONE, NEED OF TIME.pptx
byDr.Prakashkumar More
 
2025 Diabetes Management: Technology, Pharmacotherapy & Individualized Care
byArchitMehta11
 
2025 May 29th Rabies TOT MP NCDC Dr Khan Amir Maroof.pptx
byKhan Amir Maroof
 
FUTURE OF FITNESS 2025 - FITLIFE CLUB NETWORK KEYNOTE - SEATTLE 2025 BRYAN OR...
byBryan K. O'Rourke
 
GLP-1 Medicines From Metabolic Agents to Multi System Therapeutics
byArchitMehta11
 
Hyaluronic Acid Role in Combination Therapy: Advances & Application
byReza Aminnejad
 
Osteoarthritis.pdf
byGhaidaa Al-Sarayreh
 
HPM Freedom ( Metsulfuron Methyl 20% WP )
byHpm India
 
THE BIOMECHANICS OF THE JOINT MOTIONS.pptx
bydrnidhimnd
 
Flame Photometer – Standard Operating Procedure (SOP).pptx
byDebendra Suman
 
physiology pf Prgnancy, Hormones and implications
byMedicoseAcademics
 
Conc Urine formation and related disorders
byMedicoseAcademics
 
Olaparib Tablet For breast and ovarian cancers
byLetsMeds
 
Role Of Lenalidomide in Multiple Myeloma Treatment
byLetsMeds
 
Physiology of Monthly Female Menstrual Cycle
byMedicoseAcademics
 
Venetoclax Tablets for Leukemia Treatment
byLetsMeds
 
Zoledronic Acid Injection Info and price
byLetsMeds
 
PHOBIA IN DETAILS FOR MEDICAL AND NURSING STUDENTS.pptx
byDr.Prakashkumar More
 
OBSESSIVE COMPULSIVE DISORDER(OCD) IN DETAIL.pptx
byDr.Prakashkumar More
 
SONIA Trial Glucocorticoids for Community Acquired Pneumonia in Kenya
byArchitMehta11
 
SEX COUNSELLING FOR EVERYONE, NEED OF TIME.pptx
byDr.Prakashkumar More
 

Pediatric vaccines market, doses, immunization, cases and forecast worldwide analysis

  • 1.
    Pediatric Vaccines Market,Doses, Immunization, Cases and Forecast: Worldwide Analysis Renub Research www.renub.com Published: December, 2012 Copyright © 2012 Renub Research – All Rights Reserved
  • 2.
    © Renub ResearchPage 2 of 18 Pediatric Vaccines Market Analysis Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution. It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011. In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio free country. DTP are the most utilized vaccines in the pediatric vaccines market which contributed less than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine although the price of Rotavirus vaccine has declined but still its present prices are expensive than other pediatric vaccines. However despite all the impediments pediatric vaccines industry is expected to remain highly active in the future, fueled by the encouragement and financing from governments and other health organizations. Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of Cases by region in the world. This report covers in detail all aspects of past, present and future scenario. This report provides market landscape and market share information of the Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary
  • 3.
    © Renub ResearchPage 3 of 18 Vaccines Market. The report also entails major factors driving the pediatric vaccine market and challenges of pediatric vaccine market. Pediatric Vaccines Covered in this Report are as follows: Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines, Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other Pediatric Vaccines All the Pediatric Vaccines in this Report have been Studied from Four View Points:  Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011  Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015  Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015  Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015 Key Topics Covered in the Report  Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)  Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)  Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)  By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)  By Region - Pediatric Disease Cases (2001 – 2011)  Pediatric Vaccines Doses and Forecast (2005 – 2015)  Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)  All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)  Growth Drivers of Pediatric Vaccines Market  Challenges of Pediatric Vaccines Market
  • 4.
    © Renub ResearchPage 4 of 18 Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non- printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
  • 5.
    © Renub ResearchPage 5 of 18 About Us RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets. For more information on us or to view any of our sample work you can mail us at [email protected]
  • 6.
    © Renub ResearchPage 6 of 18 Published By RReennuubb RReesseeaarrcchh A–116B, Sector–27 Noida – 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: [email protected] www.renub.com © Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Renub Research, 2012 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers
  • 7.
    © Renub ResearchPage 7 of 18 Table of Contents 1. Executive Summary 2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015) 3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015) 4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015) 5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015) 5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market 5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market 5.3 Worldwide – Pediatric Proprietary Vaccines Market 6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast 6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015) 6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011) 6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses 6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines 6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines 6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015) 6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011) 6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses 6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines 6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines 6.3 Polio Vaccines and Forecast (2005 – 2015) 6.3.1 Number of Polio Cases (2001 – 2011) 6.3.2 Number of Polio Vaccines Doses 6.3.3 Immunization Coverage of Polio Vaccines 6.3.4 Market Size of Polio Vaccines 6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015) 6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011) 6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses 6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines 6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines 6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)
  • 8.
    © Renub ResearchPage 8 of 18 6.5.1 Number of Pneumococcal Cases (2000) 6.5.2 Number of Pneumococcal Vaccines Doses 6.5.3 Immunization Coverage of Pneumococcal Vaccines 6.5.4 Market Size of Pneumococcal Vaccines 6.6 Rotavirus Vaccine and Forecast (2006 – 2015) 6.6.1 Number of Rotavirus Cases (2008 & 2009) 6.6.2 Number of Rotavirus Vaccines Doses 6.6.3 Immunization Coverage of Rotavirus Vaccines 6.6.4 Market Size of Rotavirus Vaccine 6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015) 6.7.1 Number of Hepatitis Pediatric Vaccines Doses 6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines 6.7.3 Market Size of Hepatitis Pediatric Vaccines 6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015) 6.8.1 Number of Varicella/Chicken Pox Vaccines Doses 6.8.2 Market Size of Varicella/Chicken Pox Vaccines 6.9 Other Pediatric Vaccines and Forecast (2005 – 2015) 6.9.1 Market Size of Other Pediatric Vaccines 7. Growth Drivers of Pediatric Vaccines Market 7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done Error! Bookmark not defined. 7.1.1 Rotavirus Vaccine Introduction 7.1.2 Financial Challenges 7.1.3 Cost Effective 7.1.4 Future Steps 7.1.5 Conclusion 7.2 GAVI Model Increases Vaccine Manufacturers 7.2.1 The Partnership Model 7.2.2 The Business Model 7.3 WHO Global Vaccine Action Plan (2011 - 2020) 8. Challenges of Pediatric Vaccine Market 8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines 8.2 Impediment in Pediatric Vaccine Research & Development
  • 9.
    © Renub ResearchPage 9 of 18 8.3 Barriers to New Entrants in the Pediatric Vaccines Market
  • 10.
    © Renub ResearchPage 10 of 18 List of Figures Figure 2-1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011 Figure 2-2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 3-1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011 Figure 3-2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015 Figure 5-1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011 Figure 5-2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 – 2015 Figure 5-3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011 Figure 5-4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 – 2015 Figure 5-5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011 Figure 5-6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015 Figure 6-1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011 Figure 6-2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015 Figure 6-3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011 Figure 6-4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 – 2015 Figure 6-5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011 Figure 6-6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 – 2015 Figure 6-7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 – 2010 Figure 6-8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011 Figure 6-9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015 Figure 6-10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011 Figure 6-11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015 Figure 6-12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 – 2011 Figure 6-13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 – 2015
  • 11.
    © Renub ResearchPage 11 of 18 Figure 6-14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011 Figure 6-15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015 Figure 6-16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011 Figure 6-17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 – 2015 Figure 6-18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011 Figure 6-19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015 Figure 6-20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011 Figure 6-21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015 Figure 6-22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011 Figure 6-23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 – 2015 Figure 6-24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 – 2011 Figure 6-25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 – 2015 Figure 6-26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025 Figure 6-27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011 Figure 6-28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 – 2015 Figure 6-29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 – 2011 Figure 6-30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 – 2015 Figure 6-31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011 Figure 6-32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015 Figure 6-33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011 Figure 6-34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 – 2015 Figure 6-35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011 Figure 6-36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 – 2015 Figure 6-37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011 Figure 6-38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015 Figure 6-39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011 Figure 6-40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015
  • 12.
    © Renub ResearchPage 12 of 18 Figure 6-41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011 Figure 6-42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015 Figure 6-43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010 Figure 6-44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011 Figure 6-45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 6-46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011 Figure 6-47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 – 2015 Figure 6-48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011 Figure 6-49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015 Figure 6-50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011 Figure 6-51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$), 2012 – 2015 Figure 7-1: Prices of Childhood Vaccines (US$), 2011 Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012 Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets
  • 13.
    © Renub ResearchPage 13 of 18 List of Tables Table 4-1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011 Table 4-2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015 Table 6-1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011 Table 6-2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011 Table 6-3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011 Table 6-4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 – 2011 Table 6-5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011 Table 6-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011 Table 6-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011 Table 6-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011 Table 6-9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011 Table 6-10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000 Table 6-11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number), 2008 – 2009 Table 6-12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009 Table 7-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020 Table 7-2: Goal-Level Indicators, 2015 & 2020
  • 14.
    © Renub ResearchPage 14 of 18 Related Reports Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015) Asia Medical Tourism Analysis and Forecast to 2015 Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016 Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast Genetic Testing Market and Forecast - Global Analysis 2010 – 2015 USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015) Global Osteoporosis Market & Drugs Analysis 2010 – 2015 Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015) Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities, Challenges & Future Forecast
  • 15.
    © Renub ResearchPage 15 of 18 Our Partial List of Clients Bain WAKE Technology Services, Inc. PSS World Medical Relypsa C&K components Konkuk University Resonetics Samsung SEKISUI MEDICAL CO. LTD. Plentyoffish Media INC Arthur D Little Gmbh Morgan Stanley Takeda Pharmaceutical Corporation Hokkai School of Commerce Ministry of Manpower Singapore GenOmind, LLC. Goldman Sachs & Co NTT Advanced Technology Tokyo Womens Medical University The Chemo-Sero-Therapeutic Research Trade Council of Iceland Jpmorgan, Ets Trading GE Healthcare IT ixia communications Redbus Becton Dickinson Pfizer Intercell Sanofi Pasteur Stanford Burgess Pequot Capital DMI Transgene S.A. ixia communications Toyota Tsusho Amercia Inc. National Health Research Institutes Abbott Diabetes Care Corning Incorporated - Life Sciences L.E.K. Consulting GmbH Syntiron MediVas LLC Credit Suisse Dune Medical QIAGEN Inje University Mapp Biopharmaceutical Institute for Information Industry NorDiag ASA Rep e Inv Medicas SA de Innogenetics
  • 16.
    © Renub ResearchPage 16 of 18 Order Form Scan and e-mail this page to [email protected], alternatively one can also write the Contact Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780 Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to [email protected] Format Report Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis Single User (Email from Publisher) Hard Copy (Mail Delivery) CD – Rom (Mail Delivery) Global Site License (Multiple User License) US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200 For ordering this report: Three easy ways to place your order: 1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and- forecast-worldwide-analysis-86 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=86&pid=1325 To pay by Wire Transfer, please, fill in your contact details in the form below:
  • 17.
    © Renub ResearchPage 17 of 18 Bank Details Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi – 110001 India Contact Information First Name: Last Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message:
  • 18.
    © Renub ResearchPage 18 of 18 3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research A -116B Sector -27 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780 For free Sample copy report or to view any of our sample work please contact us at [email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA) Follow Us Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch